Suwon-si, South Korea

Chang Woo Lee

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Geyang-Ku, Incheon city, KR (2004)
  • Suwon-si, KR (2021 - 2023)
  • Pohang-si, KR (2023 - 2024)

Company Filing History:


Years Active: 2004-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Chang Woo Lee: Advancements in Liver Disease Treatment

Introduction

Chang Woo Lee, a prominent inventor based in Suwon-si, South Korea, has made significant contributions to the field of medical science, particularly in the treatment of liver diseases. With a total of four patents to his name, his innovations focus on pharmaceutical compositions that utilize the Ssu72 protein and related polynucleotides.

Latest Patents

Among his latest patents, the first is titled "Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same." This innovation presents a method for preventing or treating liver cancer, highlighting the administration of at least one member selected from a group that includes an Ssu72 peptide, a polynucleotide encoding the Ssu72 peptide, and an expression vector containing the polynucleotide to affected subjects.

Another notable patent is the "Pharmaceutical composition for treating non-alcoholic fatty liver, non-alcoholic steatohepatitis, or hepatic fibrosis using Ssu72 protein or a polynucleotide encoding the same." This invention offers a solution for preventing or treating various liver diseases through the use of the same group of components as mentioned in his liver cancer treatment patent.

Career Highlights

Throughout his career, Chang Woo Lee has collaborated with key companies, notably Curogen Technology Co., Ltd. and the Research & Business Foundation at Sungkyunkwan University. His work in these organizations has played an influential role in advancing his research and patent applications in the field of hepatology.

Collaborations

During his journey, Chang Woo Lee has worked alongside notable colleagues such as Mi-La Cho and Sung-Hwan Park. Their collective efforts have propelled significant advancements in the understanding and treatment of liver-related diseases, leveraging their combined expertise for impactful research outcomes.

Conclusion

Chang Woo Lee's innovative work in the realm of liver disease treatment through his patented compositions represents a notable advancement in medical research. With an impressive portfolio that highlights his commitment to improving health outcomes, his contributions continue to shape the future of liver disease therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…